2013
Revised relative potency values for PCDDs, PCDFs, and non-ortho-substituted PCBs for the optimized H4IIE-luc in vitro bioassay
LEE, K.T.; S. HONG; J.S. LEE; K.H. CHUNG; Klára HILSCHEROVÁ et al.Základní údaje
Originální název
Revised relative potency values for PCDDs, PCDFs, and non-ortho-substituted PCBs for the optimized H4IIE-luc in vitro bioassay
Autoři
LEE, K.T.; S. HONG; J.S. LEE; K.H. CHUNG; Klára HILSCHEROVÁ; J.P. GIESY a J.S. KHIM
Vydání
Environmental Science and Pollution Research, Landsberg, Germany, Ecomed, 2013, 0944-1344
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30304 Public and environmental health
Stát vydavatele
Německo
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.757
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14310/13:00071147
Organizační jednotka
Přírodovědecká fakulta
UT WoS
Klíčová slova anglicky
Dioxin-like compounds; AhR activity; In vitro bioassay; Toxic equivalency factor; Relative potency
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 9. 4. 2014 12:40, Ing. Andrea Mikešková
Anotace
V originále
While the World Health Organization 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) equivalency factors are useful estimates of relative potencies of mixtures when conducting risk assessments, they are not useful when comparing the results of bioassays such as the H4IIE-luc to concentrations of TCDD equivalents calculated from instrumental analyses. Since there are thousands of dioxin-like compounds (DLCs), one use of screening assays is to determine if all of the aryl hydrocarbon receptor (AhR) active DLCs in a mixture have been accounted for in instrumental analyses. For this purpose, bioassay-specific relative potency (ReP) values are needed. RePs of 21 polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and dioxin-like polychlorinated biphenyls that exhibit effects mediated through the AhR were determined by use of the H4IIE-luc assay. Different values of RePs are derived, depending on the statistical, curve-fitting methods used to derive them from the dose-response relationships. Here, we discuss the various methods for deriving RePs from in vitro data and their assumptions and effects on values of RePs. Full dose-response curves of 2,3,7,8-TCDD and other representative DLCs were used to estimate effective concentrations at multiple points (e.g., EC20-50-80), which were then used to estimate ReP of each DLC to 2,3,7,8-TCDD.
Návaznosti
| ED0001/01/01, projekt VaV |
|